Cargando…
Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease
Cardiovascular disease (CVD) remains a major cause of morbidity and mortality worldwide. Currently, it is well established that dyslipidemia is one of the major risk factors leading to the development of atherosclerosis and CVD. Statins remain the standard-of-care in the treatment of hypercholestero...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885448/ https://www.ncbi.nlm.nih.gov/pubmed/31798792 http://dx.doi.org/10.4330/wjc.v11.i11.256 |